Paraneoplastic Syndrome Case Presented As Nystagmus and Ataxia
Copyright © 2024, Darwesh et al..
The incidence of paraneoplastic syndrome (PNS) is on the rise, attributed to the growing detection of antibody modalities in both the serum and cerebrospinal fluid (CSF). PNS can occur as different neurological symptoms. The revised guidelines streamline the diagnostic approach but identifying PNS still requires the detection of neurological manifestations concurrent with cancer, along with the presence of specific PNS autoantibodies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Cureus - 16(2024), 2 vom: 13. Feb., Seite e55153 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Darwesh, Khaled M [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Revised 03.04.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.7759/cureus.55153 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370481550 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370481550 | ||
003 | DE-627 | ||
005 | 20240404000004.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240403s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.7759/cureus.55153 |2 doi | |
028 | 5 | 2 | |a pubmed24n1363.xml |
035 | |a (DE-627)NLM370481550 | ||
035 | |a (NLM)38558653 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Darwesh, Khaled M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Paraneoplastic Syndrome Case Presented As Nystagmus and Ataxia |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 03.04.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2024, Darwesh et al. | ||
520 | |a The incidence of paraneoplastic syndrome (PNS) is on the rise, attributed to the growing detection of antibody modalities in both the serum and cerebrospinal fluid (CSF). PNS can occur as different neurological symptoms. The revised guidelines streamline the diagnostic approach but identifying PNS still requires the detection of neurological manifestations concurrent with cancer, along with the presence of specific PNS autoantibodies | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a cancer complication | |
650 | 4 | |a cerebellar degene | |
650 | 4 | |a cerebellar-ataxia | |
650 | 4 | |a downbeat nystagmus | |
650 | 4 | |a malignancy – endometrial carcinoma – uterine bleeding – serous carcinoma | |
650 | 4 | |a paraneoplastic antibodies | |
650 | 4 | |a paraneoplastic cerebellitis | |
650 | 4 | |a paraneoplastic neurological syndromes | |
650 | 4 | |a uterine cancer | |
650 | 4 | |a vertigo | |
773 | 0 | 8 | |i Enthalten in |t Cureus |d 2013 |g 16(2024), 2 vom: 13. Feb., Seite e55153 |w (DE-627)NLM24118083X |x 2168-8184 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2024 |g number:2 |g day:13 |g month:02 |g pages:e55153 |
856 | 4 | 0 | |u http://dx.doi.org/10.7759/cureus.55153 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2024 |e 2 |b 13 |c 02 |h e55153 |